Shire acquires US rights to Resolor chronic constipation drug
This article was originally published in Scrip
Executive Summary
Shire has signed an agreement with Janssen, a subsidiary of Johnson & Johnson, where it gains the rights to develop and market Resolor (prucalopride) in the US. Terms of the deal have not been disclosed.